Milestone Pharmaceuticals Inc
(MIST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,950 | -58,388 | -45,211 | -30,655 | -14,007 |
| Depreciation Amortization | 18 | 89 | 74 | 47 | 23 |
| Other Working Capital | -1,215 | -3,262 | -1,375 | -1,951 | -2,079 |
| Other Operating Activity | 2,243 | 9,092 | 6,905 | 4,525 | 2,114 |
| Operating Cash Flow | $-13,904 | $-52,469 | $-39,607 | $-28,034 | $-13,949 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,000 | -56,852 | -39,947 | -23,000 | -8,000 |
| PPE Investments | -32 | -272 | -162 | -59 | N/A |
| Investing Cash Flow | $29,968 | $-57,124 | $-40,109 | $-23,059 | $-8,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 253 | 3,088 | 2,861 | 189 | 49 |
| Financing Cash Flow | $50,253 | $3,088 | $2,861 | $189 | $49 |
| Beginning Cash Position | 7,636 | 114,141 | 114,141 | 114,141 | 114,141 |
| End Cash Position | 73,953 | 7,636 | 37,286 | 63,237 | 92,241 |
| Net Cash Flow | $66,317 | $-106,505 | $-76,855 | $-50,904 | $-21,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,904 | -52,469 | -39,607 | -28,034 | -13,949 |
| Capital Expenditure | -32 | -272 | -162 | -59 | N/A |
| Free Cash Flow | -13,936 | -52,741 | -39,769 | -28,093 | -13,949 |